Abstract
Capsaicin (Cap) and its analogs (CAPanalogs) have diverse effects in sensory neurons including analgesia, implying they modulate other cellular targets besides the TRPV1 Cap receptor. Since Cap and CAPanalogs are not largely available and their chemical synthesis is cumbersome, they have been obtained through a direct lipase-catalyzed reaction. Capsiate, the ester CAPanalog, was synthesized using a novel enzymatic transacylation one-pot strategy. Five different CAPanalogs were synthesized by amidation in 2-methyl-2-butanol with higher yields than previously reported. Voltage-dependent Ca 2+ channels (Ca vs) are among the main Ca 2+ entry paths into cells. They are classified as high-voltage-activated Ca 2+ channels (HVA) and low-voltage-activated Ca 2+ channels (LVA) constituted only by T-type channels. Though HVA Ca vs are Cap sensitive, it is not known if capsaicinoids inhibit LVA Ca vs which participate in the primary sensory neuron pain pathway. Here we first report that Cap, dihydrocapsaicin, N-VAMC 8, N-VAMC 9, and N-VAMC 10 can directly and partially reversibly inhibit T-type Ca vs, whereas olvanil, capsiate, and vanillylamine cannot. The Cap inhibition of T-type Ca vs was independent of TRPV1 activation.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Biochemical and Biophysical Research Communications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
